These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2473129)

  • 1. Immune response to a synthetic peptide corresponding to an epitope of a parasitophorous vacuole membrane antigen from Plasmodium falciparum.
    Kara U; Pye D; Lord R; Pam C; Gould H; Geysen M; Jones G; Stenzel D; Kidson C; Saul A
    J Immunol; 1989 Aug; 143(4):1334-9. PubMed ID: 2473129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of antibodies against the Plasmodium falciparum p126 antigen in non-responder H-2b and partial-responder H-2d mice using synthetic peptides.
    Gilardeau Truffinet M; Bossus M; Camus D; Delplace P; Mazingue C; Diesis E; Tartar A; Moreau S; Gras-Masse H; Banic DM
    Pept Res; 1996; 9(2):61-70. PubMed ID: 8738980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protective merozoite protein of Plasmodium falciparum shares an epitope with surface antigens of Paramecium.
    Sehgal A; Singh NJ; Chakraborty T; Sharma S
    Parasite Immunol; 2004 May; 26(5):219-27. PubMed ID: 15491471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium falciparum: an epitope within a highly conserved region of the 47-kDa amino-terminal domain of the serine repeat antigen is a target of parasite-inhibitory antibodies.
    Fox BA; Xing-Li P; Suzue K; Horii T; Bzik DJ
    Exp Parasitol; 1997 Feb; 85(2):121-34. PubMed ID: 9030663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice immunized with a synthetic peptide construct corresponding to an epitope present on a Plasmodium falciparum antigen are protected against Plasmodium chabaudi challenge.
    Lord R; Jones GL; Spencer L; Saul A
    Parasite Immunol; 1993 Nov; 15(11):613-8. PubMed ID: 7533280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
    Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium falciparum: further characterization of a functionally active region of the merozoite invasion ligand EBA-175.
    Sim BK; Carter JM; Deal CD; Holland C; Haynes JD; Gross M
    Exp Parasitol; 1994 May; 78(3):259-68. PubMed ID: 7512929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
    Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH
    J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High titer response against a malarial antigen depends on the flanking sequence of the immunizing peptide conjugate.
    Jones GL; Gale J; Lord R; Edmundson HM; Saul A; Pye D
    Pept Res; 1989; 2(4):282-5. PubMed ID: 2520766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii.
    Burns JM; Majarian WR; Young JF; Daly TM; Long CA
    J Immunol; 1989 Oct; 143(8):2670-6. PubMed ID: 2477452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immune responses to vaccine peptides derived from the circumsporozoite protein of Plasmodium falciparum.
    Russo DM; Sundy JS; Young JF; Maguire HC; Weidanz WP
    J Immunol; 1989 Jul; 143(2):655-9. PubMed ID: 2472448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of the C-terminal 19-kDa fragment of the Plasmodium falciparum merozoite surface protein 1 (MSP1), YMSP1(19) expressed in S. cerevisiae.
    Hui GS; Gosnell WL; Case SE; Hashiro C; Nikaido C; Hashimoto A; Kaslow DC
    J Immunol; 1994 Sep; 153(6):2544-53. PubMed ID: 8077664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antibody response in BALB/c mice to the Plasmodium falciparum circumsporozoite repetitive epitope covalently coupled to synthetic lipopeptide adjuvant.
    Wiesmüller KH; Jung G; Gillessen D; Loffl C; Bessler WG; Böltz T
    Immunology; 1991 Jan; 72(1):109-13. PubMed ID: 1705236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of adjuvants on the antibody specificity to the Plasmodium falciparum major merozoite surface protein, gp195.
    Hui GS; Chang SP; Gibson H; Hashimoto A; Hashiro C; Barr PJ; Kotani S
    J Immunol; 1991 Dec; 147(11):3935-41. PubMed ID: 1940375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of the human monoclonal antibody 33G2 with repeated sequences of three distinct Plasmodium falciparum antigens.
    Udomsangpetch R; Carlsson J; Wåhlin B; Holmquist G; Ozaki LS; Scherf A; Mattei D; Mercereau-Puijalon O; Uni S; Aikawa M
    J Immunol; 1989 May; 142(10):3620-6. PubMed ID: 2654292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of antibody specificity to Plasmodium falciparum merozoite surface protein-1 by adjuvant and MHC haplotype.
    Chang SP; Nikaido CM; Hashimoto AC; Hashiro CQ; Yokota BT; Hui GS
    J Immunol; 1994 Apr; 152(7):3483-90. PubMed ID: 8144929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tandem use of PCR and synthetic peptides to map helper T-cell epitopes on 27-kDa sexual stage antigen of Plasmodium falciparum.
    Koski GK; Ploton IN; Viscidi R; Kumar N
    Pept Res; 1996; 9(3):127-35. PubMed ID: 8875592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of synthetic immunogens: use of T- and B-cell epitopes of CS and RESA proteins of Plasmodium falciparum.
    Ritu G; Rao DN
    Vaccine; 1992; 10(11):761-5. PubMed ID: 1279906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of synthetic carriers and adjuvants for increasing the immunogenicity of a synthetic peptide from the CS-protein of Plasmodium falciparum].
    Ivanov BB; Meshcheriakova EA; Andronova TM; Ivanov VT
    Bioorg Khim; 1991 Jun; 17(6):732-46. PubMed ID: 1723268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.